Activist AREX Capital wins one seat in proxy fight at Enhabit
Changes sourcing in lead, adds new details throughout
By Svea Herbst-Bayliss
July 25 (Reuters) - Enhabit EHAB.N investors elected one of AREX Capital Management's director nominees after the activist investor called on them to replace seven of the home health and hospice provider's directors to help improve financial performance.
Enhabit said on Thursday shareholders added Mark Ohlendorf to the board and re-elected eight of the company's nine legacy directors, including the chief executive officer and two directors who joined last year when Enhabit reached an agreement with another activist investor.
Reuters first reported AREX won one seat and that Ohlendorf, who has experience as a public company chief financial officer, was chosen. He will replace Susan LaMonica who joined Enhabit's board as an independent director in 2022.
Enhabit's fight with AREX is one of only a handful of activist investors' campaigns to have made it to a vote this year, underscoring many investors' and companies' preference to reach agreements for board seats and other concessions before shareholders weigh in.
While Enhabit has many hedge fund investors who were thought to back AREX, it also counts the three main index funds - BlackRock BLK.N, Vanguard and State Street STT.N - as big shareholders. In this vote those three sided with management's candidates, sources familiar with the preliminary vote tally said.
These investors ignored the recommendations of proxy advisory firms Institutional Shareholder Services (ISS) and Glass Lewis who had urged investors to elect three AREX nominees, arguing the company needed more expertise in the home health and hospice business and public company financial reporting.
Enhabit's share price has tumbled roughly 60% since it was spun off of post-acute healthcare services provider Encompass Health EHC.N in July 2022. It climbed nearly 10% in the last five days and was up nearly 4% in midday trading on Thursday.
AREX, which owns a 4.9% stake in Enhabit, urged management last year to immediately start a strategic review. Enhabit in May decided to continue as an independent company and urged investors to stick with its directors now, arguing big changes could jeopardize recent improvements.
In 2023, the company reached a settlement with Cruiser Capital and Harbour Point Capital Management and appointed two new directors to the board.
Reporting by Svea Herbst-Bayliss
Editing by Chris Reese
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
